Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Molecular Neurodegeneration
|
March 17, 2023
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications
Fernando Gonzalez-Ortiz, Przemysław R Kac, Wagner S Brum, et al.
Plos One
|
November 9, 2022
Impact of the COVID-19 pandemic on early career dementia researchers: A global online survey
Sara Laureen Bartels, C Elizabeth Shaaban, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 25, 2022
ISTAART Professional Interest Area to Elevate Early Career Researchers and University College London survey turns a spotlight on early career researcher life and challenges
Adam Smith, C Elizabeth Shaaban, Sara Laureen Bartels, et al.
JAMA Neurology
|
December 1, 2025
Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis
Michael Malek-Ahmadi, Savar Sharma, Fawaz Stipho, et al.
JAMA Neurology
|
December 18, 2023
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial
Wagner S Brum, Kieran F Docherty, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 14, 2022
Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
Joel Simrén, Haley Weninger, Wagner S Brum, et al.
Alzheimer'S Research & Therapy
|
February 8, 2022
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Andréa L Benedet, Wagner S Brum, Oskar Hansson, et al.
Alzheimer'S Research & Therapy
|
June 22, 2024
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers
Anna Orduña Dolado, Erik Stomrud, Nicholas J Ashton, et al.
Brain : a Journal of Neurology
|
February 7, 2024
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 14, 2022
Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models
Nicholas C Cullen, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Molecular Neurodegeneration
|
March 17, 2023
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications
Fernando Gonzalez-Ortiz, Przemysław R Kac, Wagner S Brum, et al.
Plos One
|
November 9, 2022
Impact of the COVID-19 pandemic on early career dementia researchers: A global online survey
Sara Laureen Bartels, C Elizabeth Shaaban, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 25, 2022
ISTAART Professional Interest Area to Elevate Early Career Researchers and University College London survey turns a spotlight on early career researcher life and challenges
Adam Smith, C Elizabeth Shaaban, Sara Laureen Bartels, et al.
JAMA Neurology
|
December 1, 2025
Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis
Michael Malek-Ahmadi, Savar Sharma, Fawaz Stipho, et al.
JAMA Neurology
|
December 18, 2023
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial
Wagner S Brum, Kieran F Docherty, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 14, 2022
Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
Joel Simrén, Haley Weninger, Wagner S Brum, et al.
Alzheimer'S Research & Therapy
|
February 8, 2022
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Andréa L Benedet, Wagner S Brum, Oskar Hansson, et al.
Alzheimer'S Research & Therapy
|
June 22, 2024
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers
Anna Orduña Dolado, Erik Stomrud, Nicholas J Ashton, et al.
Brain : a Journal of Neurology
|
February 7, 2024
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 14, 2022
Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models
Nicholas C Cullen, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Page
of 6